Presbyopia is inevitable for all patients, but with new products hitting the market and coming down the pipeline, it is becoming increasingly easier to manage. Blake Williamson, MD, MPH, and his cohost, Neda Nikpoor, MD, welcome Karl G. Stonecipher, MD, for an in-depth discussion about how they currently treat presbyopia and how they expect the management of this condition to evolve as new mechanisms of action are developed, FDA approved, and released.